Provided by Tiger Fintech (Singapore) Pte. Ltd.

IDEAYA Biosciences

18.42
+0.24001.32%
Volume:754.72K
Turnover:13.85M
Market Cap:1.61B
PE:-5.48
High:18.57
Open:18.29
Low:17.99
Close:18.18
Loading ...

BRIEF-IDEAYA Announces Oral Presentation at the New Drugs on the Horizon Series at AACR 2025 for IDE275 (GSK959), a Phase 1 Werner Helicase Inhibitor

Reuters
·
26 Mar

IDEAYA Announces Oral Presentation at the New Drugs on the Horizon Series at Aacr 2025 for Ide275 (GSK959), a Phase 1 Werner Helicase Inhibitor

THOMSON REUTERS
·
26 Mar

IDEAYA Biosciences, Inc. (IDYA) Partners with ATTMOS for AI-Driven Drug Discovery Platform

Insider Monkey
·
06 Mar

IDEAYA Biosciences, ATTMOS Collaborate to Advance Small Molecule Discovery for Undruggable Oncology Targets

MT Newswires Live
·
04 Mar

Ideaya Biosciences announces research collaboration with Attmos

TIPRANKS
·
03 Mar

IDEAYA Biosciences Announces Collaboration With Attmos to Accelerate AI/Ml-Enabled Drug Discovery for Unprecedented First-in-Class Oncology Targets

THOMSON REUTERS
·
03 Mar

IDEAYA Biosciences Announces Collaboration with ATTMOS to Accelerate AI/ML-Enabled Drug Discovery for Unprecedented First-in-Class Oncology Targets

PR Newswire
·
03 Mar

IDEAYA Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS
·
28 Feb

IDEAYA Biosciences Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

PR Newswire
·
28 Feb

Cautious Hold Rating on IDEAYA Biosciences Amid Anticipated Equity Raises and Financial Pressures

TIPRANKS
·
23 Feb

IDEAYA Biosciences Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
18 Feb

U.S. RESEARCH ROUNDUP-Boeing, Philip Morris, Walmart

Reuters
·
17 Feb

IDEAYA Biosciences Inc : Jefferies Cuts Target Price to $50 From $60

THOMSON REUTERS
·
17 Feb

IDEAYA Biosciences Reports 2024 Financials and Business Update

TIPRANKS
·
15 Feb

Wedbush Keeps Their Buy Rating on IDEAYA Biosciences (IDYA)

TIPRANKS
·
14 Feb

RBC Lowers Price Target on IDEAYA Biosciences to $57 From $61, Keeps Outperform, Speculative Risk

MT Newswires Live
·
14 Feb

U.S. RESEARCH ROUNDUP-Airbnb, CVS Health, Roku

Reuters
·
14 Feb

Strategic Advancements and Clinical Progress Drive IDEAYA Biosciences’ Buy Rating

TIPRANKS
·
14 Feb

BUZZ-Ideaya Biosciences falls as quarterly loss widens

Reuters
·
13 Feb

IDEAYA Biosciences Launching Gilead Trial Collaboration to Evaluate Trodelvy, IDE397 Combination in Lung Cancer

MT Newswires Live
·
13 Feb